Price range: $75.00 through $236.00
Catalog Number: 12255-05021
Purified antibody validated for specificity and sensitivity.
| Format | IgG-Biotin Conjugate |
|---|---|
| Entrez Gene | 2159 |
| Associated Disease | Blood Disorder |
| Species | Human |
| UniProt | P00742 |
| Size | Full Size, Trial Size |
| Purity | Affinity Purified |
| Presentation | 0.25% BSA, 50% Glycerol, and 0.02% Sodium Azide, PBS pH 7.4 |
| Host | Rabbit |
| Storage | -20°C or below |
| Application | EIA/RIA |
| Immunogen | Human FXa purified from human plasma |
| Label | Biotin conjugated |
FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms
Spike Protein Subunits of SARS‐CoV‐2 Alter Mitochondrial Metabolism in Human Pulmonary Microvascular Endothelial Cells: Involvement of Factor Xa
Compression stockings attenuate the expression of proteins associated with vascular damage in human varicose veins
Modificación de mecanismos asociados a la patogénesis y evolución de aneurismas de aorta abdominal mediante inhibición del factor Xa con rivaroxabán
FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms
Modification of mechanisms associated with the pathogenesis and evolution of abdominal aortic aneurysms by factor Xa inhibition with rivaroxaban
* Monux G et al. (2017) FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms. Br J Clin Pharmacol. 83(12):2661-2670.
* Marques de Marino P(2021) Modification of mechanisms associated with the pathogenesis and evolution of abdominal aortic aneurysms by factor Xa inhibition with rivaroxaban. Complutense University of Madrid. Ph.D. Thesis.
Loading data...
